Trial Profile
A Phase 1 Study of Substance P-Saporin in Terminal Cancer Patients With Intractable Pain
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 22 May 2018
Price :
$35
*
At a glance
- Drugs Substance P saporin (Primary)
- Indications Cancer pain
- Focus Therapeutic Use
- Acronyms SP-SAP
- 09 May 2018 Status changed from recruiting to completed.
- 09 May 2018 Status changed from recruiting to completed.
- 07 Jun 2016 Planned End Date changed from 1 Mar 2016 to 1 Mar 2018.